... The company is backed by Biomark Capital, a life sciences and healthcare investment firm with offices in Greenwich, CT and San Francisco, CA. Investor and media contact: Douglas D. Lind, MD Interim Chief Executive Officer Opus Bio, Inc. (203) ...
http://www.freshnews.com/news/976419/lentigen-corporation-announces-sale-lentiviral-vector-manufacturing-business-and-change
http://www.freshnews.com/news/976419/lentigen-corporation-announces-sale-lentiviral-vector-manufacturing-business-and-change
No comments:
Post a Comment
Useful criticism, helpful links and corrections and general comments are always welcome at Greenwich Roundup. Generally only spam ads and posts with very foul language get censored.
Contact me directly at GreenwichRoundup@gmail.com if you have a suggestion or comment you don't want publicized (but tell me so in your email).
I look forward to publishing your opinions.
COMMENTING RULES: We encourage an open exchange of ideas in the Greenwich community, but we ask you to follow our guidelines. Basically, be civil, smart, on-topic and free from profanity. Don't say anything you wouldn't want your mother to read!